CACNA1C基因多态性与双相障碍患者血清BDNF水平的关联
该研究在282例双相障碍患者和90名对照中分析了6个CACNA1C变异与脑脊液或血清中39种生物标志物的关系,发现CACNA1C风险等位基因与血清BDNF及组织型纤溶酶原激活剂水平相关,提示CACNA1C遗传变异与双相障碍病理生理机制的联系。
要点
- CACNA1C风险等位基因与双相障碍患者血清BDNF水平相关。
- CACNA1C风险等位基因还与组织型纤溶酶原激活剂水平相关。
- 该关联提示CACNA1C变异可能通过BDNF通路影响双相障碍病理机制。
核心结论
- CACNA1C风险等位基因与双相障碍患者血清BDNF及组织型纤溶酶原激活剂水平存在关联。
研究设计与样本
- 研究纳入282例双相障碍患者和90名对照,分析6个CACNA1C变异与脑脊液或血清中39种生物标志物的关系。
主要发现
- CACNA1C风险等位基因与血清BDNF水平相关。
- CACNA1C风险等位基因与组织型纤溶酶原激活剂水平相关,该酶可将pro-BDNF转化为成熟BDNF。
临床怎么用
- 该发现为理解CACNA1C遗传变异与双相障碍病理生理机制的联系提供了线索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Variation in the CACNA1C gene has been associated with bipolar disorder in several genome-wide association studies. This gene encodes the alpha 1C subunit of L-type voltage-gated calcium channels, which play an essential role in neurons. We analysed 39 biomarkers in either cerebrospinal fluid or serum in relation to six different CACNA1C variants in 282 patients with bipolar disorder and 90 controls. We report associations of CACNA1C risk alleles with serum levels of BDNF as well as tissue plasminogen activator, which converts pro-BDNF to mature BDNF. This sheds light on links between CACNA1C genetic variants and pathophysiological mechanisms in bipolar disorder.
引用
- Smedler E, Pålsson E, Hashimoto K, et al. Association of CACNA1C polymorphisms with serum BDNF levels in bipolar disorder. Br J Psychiatry. 2021. PMID: 31317860. doi:10.1192/bjp.2019.173
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。